Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes

BACKGROUND: Markers of bone and extracellular matrix (ECM) remodeling may be associated with adverse outcomes in atherosclerotic cardiovascular disease. Podocan is a newly discovered ECM glycoprotein, previously not studied in a chest pain population. We wanted to study the association between Podoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Thomas, Ueland, Thor, Aukrust, Pål, Nilsen, Dennis W., Grundt, Heidi, Staines, Harry, Kontny, Frederic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163367/
https://www.ncbi.nlm.nih.gov/pubmed/35669474
http://dx.doi.org/10.3389/fcvm.2022.867944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163367/
https://www.ncbi.nlm.nih.gov/pubmed/35669474
http://dx.doi.org/10.3389/fcvm.2022.867944

Ejemplares similares